Bull Horn Holdings in a proxy filing seeks a merger deadline extension from Nov. 3 to Dec. 31. The SPAC said it needs more time to finalize arrangements on its merger deal with Coeptis Therapeutics, a biopharmaceutical company developing cell therapy platforms for cancer.
Following an extension vote back in April, redemptions of $43 million left $32.7 million in the SPAC’s trust. Read more.
